Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Randomized Controlled Trial of Spironolactone in Young Women With Nonalcoholic Steatohepatitis (NASH)

NCT03576755 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03576755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Randomized Controlled Trial of Spironolactone in Young Women With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
January 9, 2019
Completion date
July 5, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nash - nonalcoholic steatohepatitis